Citigroup Lowers PT on Charles River Laboratories to $31

Symbols: CRL
Tags: Citigroup
Share

Citigroup has lowered the price target on Charles River Laboratories (NYSE: CRL) from $34 to $31 and maintains its Neutral rating.


 
 
< Previous
Deutsche Bank Upgrades Skyworks to Buy
Next >
Citigroup Raises PT on Lamar Advertising to $26
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust